| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/16/2006 | US7045353 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells |
| 05/16/2006 | US7045299 Digestive diseases; amino acid sequence 20 or 21; specific to orphan receptor protein ZAQ |
| 05/16/2006 | US7045290 Prevention protein misfolding; central nervous system disorders; Alzheimer's, Parkinson's, Huntington's disease therapy |
| 05/16/2006 | US7045148 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 05/16/2006 | US7045140 Therapeutic delivery of carbon monoxide |
| 05/16/2006 | US7045118 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/16/2006 | CA2260296C Variants of human ciliary neurotrophic factor (hcntf) with a range of action different from that of the wild-type molecule |
| 05/16/2006 | CA2237752C Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/16/2006 | CA2227386C Piperazine derivatives and their use as 5-ht1a antagonists |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/16/2006 | CA2192535C 2-naphtamides derivatives and therapeutic uses thereof |
| 05/11/2006 | WO2006050165A2 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
| 05/11/2006 | WO2006050037A1 Adjunctive therapy for depression |
| 05/11/2006 | WO2006049336A1 Method of preparing stem cells and tissue remedy |
| 05/11/2006 | WO2006049312A1 Remedy for neuropathic pain |
| 05/11/2006 | WO2006049258A1 Polymeric polyphenol extracted from fermented tea, therapeutic agent for mitochondrial disease, preventive/therapeutic agent for diabetes mellitus, and food or beverage |
| 05/11/2006 | WO2006049248A1 Analgesic |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | WO2006048771A1 Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 05/11/2006 | WO2006048727A1 Piperazinylphenalkyl lactam/amine ligands for the 5ht1b receptor |
| 05/11/2006 | WO2006048501A1 A transmucosal veterinary composition comprising detomidine |
| 05/11/2006 | WO2006048446A1 Lactobacillus for preventing and/or treating chronique fatigue syndrome and associated diseases |
| 05/11/2006 | WO2006048295A1 Composition compri sing vlp and amyloid - beta peptide |
| 05/11/2006 | WO2006048208A1 Bilayer tablet comprising telmisartan and amlodipine |
| 05/11/2006 | WO2006048146A1 Quinoline as allosteric enhancers of the gaba-b receptors |
| 05/11/2006 | WO2006035414A3 Carbidopa and levodopa dispersible tablets |
| 05/11/2006 | WO2006031720A3 D-methionine formulation with improved biopharmaceutical properties |
| 05/11/2006 | WO2006013546A3 Process for the preparation of pure galantamine |
| 05/11/2006 | WO2005116212A3 Treatment of neurodegenerative disease through intracranial delivery of sirna |
| 05/11/2006 | WO2005107808A3 Combination of atypical antipsychotics and 5-ht1b receptor antagonists |
| 05/11/2006 | WO2005106471A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 4 (ccr4) |
| 05/11/2006 | WO2005089731A3 Use of renin inhibitors in therapy |
| 05/11/2006 | WO2005079753A3 Extended release pharmaceutical compositions of divalproex sodium |
| 05/11/2006 | WO2002098351A8 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | US20060100427 Alzheimer's disease and other diseases relating to amyloid deposits; neurodegenerative diseases |
| 05/11/2006 | US20060100283 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 05/11/2006 | US20060100261 Furan or thiopene derivative and medicinal use thereof |
| 05/11/2006 | US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 05/11/2006 | US20060100248 alleviating vision defects, multiple sclerosis, neurodegenerative diseases, stroke, spinal cord injury, Alzheimer's disease, Parkinson's disease or pain, comprising administering sodium channel modulators comprising pyrazole or indazole derivatives, such as 3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole |
| 05/11/2006 | US20060100245 Substituted biphenyl-4-carboxylic acid arylamide analogues |
| 05/11/2006 | US20060100244 Such as (3-chloro-4-fluorophenyl)(4-fluoro-4-{[(5-hydoxypyridin-2-ylmethyl)amino]methyl}piperidin-1-yl)methanone; serotonin receptor agonists; for treating depression, pain, and substance abuse |
| 05/11/2006 | US20060100242 4-(2-Phenylsulfanyl-phenyl)-piperidine derivates as serotonin reuptake inhibitors |
| 05/11/2006 | US20060100233 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100222 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/11/2006 | US20060100202 Novel compounds |
| 05/11/2006 | US20060100196 Substituted amines for the treatment of alzheimer's disease |
| 05/11/2006 | US20060100192 Heteroaryl diazacycloalkanes, their preparation and use |
| 05/11/2006 | US20060100184 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 05/11/2006 | US20060100175 Novel therapeutic use of low molecular weight heparins |
| 05/11/2006 | US20060100159 Preventing desensitization of receptors |
| 05/11/2006 | US20060100152 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules |
| 05/11/2006 | US20060100141 Administering peptidic or peptidomimetic compound having segment competent for importation of molecule into mast cells, and asecond segment for having an anti-allergic effect within mast cells for reducing late phase inflammatory responses induced by mitogen activated protein kinase activation |
| 05/11/2006 | US20060100137 Monodispersed insulin polypeptide-oligomer conjugates; for administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes |
| 05/11/2006 | US20060099682 Human vanilloid receptors and their uses |
| 05/11/2006 | US20060099672 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types for example |
| 05/11/2006 | US20060099640 SLO2 and SLO4, novel potassium channel proteins from human brain |
| 05/11/2006 | US20060099585 Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases |
| 05/11/2006 | US20060099276 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/11/2006 | US20060099263 Antidepressant dosage form |
| 05/11/2006 | US20060099255 solid dosage forms for oral administration, reducing the range in daily dosages required to control pain in human patients |
| 05/11/2006 | US20060099179 Delivering an adeno-associated virus vector comprising a nucleotide sequence encoding glutamic acid decarboxylase to cells in specific areas of the brain; Parkinson's Disease, Alzheimer's Disease, Amyloid Lateral Sclerosis, and epilepsy |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | DE10356925B4 Inhalator für basische pharmazeutische Wirkstoffe sowie Verfahren für dessen Herstellung An inhaler for basic pharmaceutical agents, and methods for its preparation |
| 05/11/2006 | DE102004054053A1 New 2-(hetero)aryl-imidazoline or tetrahydropyrimidine derivatives, are bradykinin B1 receptor antagonists used e.g. for treating neuropathic or inflammatory pain or migraine |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2587481A1 Phenylalkylamino carbamates adjunctive therapy for depression |
| 05/11/2006 | CA2586254A1 Therapeutic agent for neuropathic pain |
| 05/11/2006 | CA2586066A1 Quinoline as allosteric enhancers of the gaba-b receptors |
| 05/11/2006 | CA2585967A1 Substituted indolizines and derivatives as cns agents |
| 05/11/2006 | CA2585471A1 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
| 05/11/2006 | CA2584676A1 Polymorphs of sarsapogenin |
| 05/11/2006 | CA2581300A1 Composition comprising vlp and amyloid-beta peptide |
| 05/10/2006 | EP1655990A1 Wireless microphone communication system |
| 05/10/2006 | EP1655305A2 Therapeutic anti-cytomegalovirus compounds |
| 05/10/2006 | EP1655287A1 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 05/10/2006 | EP1655032A1 Compounds for the treatment of autoimmune and demyelinating diseases |
| 05/10/2006 | EP1655030A1 Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/10/2006 | EP1655029A1 Medicinal compositions |
| 05/10/2006 | EP1655027A1 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension and migraine |
| 05/10/2006 | EP1655023A1 Botulinum toxin implat |
| 05/10/2006 | EP1654352A1 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration |
| 05/10/2006 | EP1654264A1 Spiro [1-azabicyclo [2.2.2]octane-3,5'-oxazolidin-2'-one] derivatives with affinity to the alpha7 nicotinic acetylcholine receptor |
| 05/10/2006 | EP1654260A2 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders |
| 05/10/2006 | EP1654258A1 Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 05/10/2006 | EP1654255A1 Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
| 05/10/2006 | EP1654241A1 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof |
| 05/10/2006 | EP1654231A2 Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 05/10/2006 | EP1653971A2 Treatment of sleep disorders with cholinesterase inhibitors |
| 05/10/2006 | EP1653963A1 Nasal pharmaceutical composition of piribedil |
| 05/10/2006 | EP1653956A1 Combinations of paroxetine and 4-(s)-(4-acetyl-piperazin-1-yl)-2-(r)-(4-fluoro-2-methyl-phenyl)-piperidine-1-carboxylic acid ¬1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl|methylamide for treatment of depression and/or anxiety. |
| 05/10/2006 | EP1653952A2 Oxazole compounds for the treatment of neurodegenerative disorders |
| 05/10/2006 | EP1441742A4 Axon repair |
| 05/10/2006 | EP1432991A4 Identification and isolation of somatic stem cells and uses thereof |
| 05/10/2006 | EP1418911B1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 05/10/2006 | EP1412354B1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS |
| 05/10/2006 | EP1379694B1 Methods and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 05/10/2006 | EP1370553B1 Rho-kinase inhibitors |